elranatamab
pfizer
['mmsm', 'elranatamab']
shoutout to my colleague #asco22 for oral presentation on the phase 2 trial of elranatamab, a b-cell maturation antigen (bcma)-cd3 bispecific antibody, in patients (pts) with relapsed/refractory mm. #mmsm 
Chief of Myeloma @MSKCancerCenter | Chair @ALLIANCE_org #mmsm Comm. |Physician ? Provider| @ASH_hematology @ASTCT @ASCO |married to @ZainabShd | #BMTsm #CARTsm